# Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection

> **NCT03516669** · PHASE4 · COMPLETED · sponsor: **Mackay Memorial Hospital** · enrollment: 20 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Clarithromycin
- **DRUG:** Amoxicillin, Clarithromycin

## Key facts

- **NCT ID:** NCT03516669
- **Lead sponsor:** Mackay Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-07
- **Primary completion:** 2018-12-28
- **Final completion:** 2019-02-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03516669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03516669, "Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03516669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*